Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.375 USD | +12.56% | -9.77% | -10.45% |
05-02 | Cyclacel Pharmaceuticals, Inc. announced that it has received $8.000001 million in funding | CI |
04-30 | Top Midday Gainers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.45% | 2.78M | |
+3.94% | 106B | |
+7.02% | 23.47B | |
-14.71% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-10.10% | 16.78B | |
+5.65% | 14.41B | |
+35.22% | 12.86B | |
+326.33% | 8.78B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Earnings Flash (CYCC) CYCLACEL Posts Q2 Revenue $373,000